Correction to: BMC Cancer (2018) 18:577 DOI https://doi.org/10.1186/s12885-018-4345-2
It has been highlighted that in the original manuscript [1] Fig. 1 was omitted and Fig. 2 appeared twice. This Correction article shows the correct Fig. 1. The original article has been updated.
Human tumors may up- or down-regulate PK genes. Each gene was scored relative to a composite-normal reference to generate conservative. Q6 f1:2 estimates of aberrant somatic gene expression. RSEM normalized gene expression data were used. The expression score of each gene in each tumor. f1:3 sample is the signed Z-score relative to normal tissue samples. Example probability density distributions of gene expression for two genes are shown: f1:4 (Left) drug importer SLC16A2 and (Right) drug exporter ABCC5
Reference
Zimmermann MT, et al. The impact of pharmacokinetic gene profiles across human cancers. BMC Cancer. 2018) May;18:577.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Zimmermann, M.T., Therneau, T.M. & Kocher, JP.A. Correction to: the impact of pharmacokinetic gene profiles across human cancers. BMC Cancer 18, 743 (2018). https://doi.org/10.1186/s12885-018-4593-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12885-018-4593-1